oxaprozin

FDA Drug Profile — COXANTO

oxaprozin is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including COXANTO. Available dosage form: capsule.

Drug Details

Generic Name
oxaprozin
Brand Names
COXANTO
Application Number
NDA217927
Sponsor
SOLA Pharmaceuticals, LLC
NDC Codes
1
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
OXAPROZIN

Indications and Usage

1 INDICATIONS AND USAGE OXAPROZIN is indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For relief of the signs and symptoms of juvenile rheumatoid arthritis OXAPROZIN CAPSULES is a non-steroidal anti-inflammatory drug indicated for: Relief of signs and symptoms of Osteoarthritis (OA) (1) Relief of signs and symptoms of Rheumatoid Arthritis (RA) (1) Relief of signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) (1)